Verdence Capital Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.88M Buy
14,356
+4,185
+41% +$1.25M 0.23% 103
2025
Q4
$3.36M Sell
10,171
-5,656
-36% -$1.92M 0.2% 111
2025
Q3
$5.79M Sell
15,827
-235
-1% -$71.1K 0.33% 68
2025
Q2
$5.01M Sell
16,062
-2,707
-14% -$1.03M 0.34% 70
2025
Q1
$9.83M Buy
18,769
+1,732
+10% +$885K 0.75% 25
2024
Q4
$8.62M Buy
17,037
+80
+0.5% +$45.5K 0.69% 30
2024
Q3
$9.91M Buy
16,957
+239
+1% +$135K 0.79% 21
2024
Q2
$8.51M Buy
16,718
+134
+0.8% +$65.7K 0.76% 24
2024
Q1
$8.2M Sell
16,584
-357
-2% -$181K 0.75% 26
2023
Q4
$8.92M Buy
16,941
+342
+2% +$182K 0.86% 19
2023
Q3
$8.37M Buy
16,599
+2,340
+16% +$1.15M 0.91% 19
2023
Q2
$6.85M Buy
14,259
+78
+0.6% +$38.1K 0.8% 25
2023
Q1
$6.7M Buy
14,181
+3,116
+28% +$1.5M 0.81% 23
2022
Q4
$5.87M Sell
11,065
-2,427
-18% -$1.29M 0.72% 27
2022
Q3
$6.81M Sell
13,492
-122
-0.9% -$64.2K 0.94% 17
2022
Q2
$6.99M Sell
13,614
-336
-2% -$169K 0.9% 17
2022
Q1
$7.11M Buy
13,950
+6,044
+76% +$2.92M 0.81% 25
2021
Q4
$3.97M Buy
7,906
+5,597
+242% +$2.53M 0.47% 54
2021
Q3
$902K Buy
2,309
+317
+16% +$131K 0.12% 183
2021
Q2
$797K Buy
1,992
+80
+4% +$31.9K 0.11% 191
2021
Q1
$712K Buy
1,912
+15
+0.8% +$5.2K 0.12% 178
2020
Q4
$665K Buy
1,897
+37
+2% +$12.4K 0.13% 169
2020
Q3
$580K Buy
1,860
+141
+8% +$43.3K 0.13% 173
2020
Q2
$507K Buy
1,719
+53
+3% +$15.2K 0.12% 172
2020
Q1
$416K Buy
1,666
+1
+0.1% +$275 0.12% 177
2019
Q4
$490K Buy
1,665
+18
+1% +$4.71K 0.12% 178
2019
Q3
$358K Buy
1,647
+27
+2% +$6.51K 0.1% 207
2019
Q2
$395K Buy
1,620
+3
+0.2% +$722 0.11% 196
2019
Q1
$400K Buy
1,617
+325
+25% +$82.9K 0.11% 180
2018
Q4
$322K Sell
1,292
-10
-0.8% -$2.64K 0.09% 182
2018
Q3
$346K Sell
1,302
-1,064
-45% -$277K 0.09% 192
2018
Q2
$581K Sell
2,366
-116
-5% -$27.9K 0.14% 157
2018
Q1
$531K Buy
2,482
+14
+0.6% +$3.2K 0.13% 159
2017
Q4
$544K Buy
+2,468
New +$523K 0.13% 142

Other funds holding UNH

Verdence Capital Advisors's UNH Position: Q1 2026 in Review

Verdence Capital Advisors increased its UnitedHealth (UNH) stake by 41% in Q1 2026, buying an estimated $1.25M and bringing the position to 14,356 shares worth $3.88M. The position accounts for 0.23% of the portfolio, ranked #103.

Verdence Capital Advisors first reported a position in UNH in Q4 2017 and has held it in 34 quarters since. The position peaked at $9.91M in Q3 2024. 3,021 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Verdence Capital Advisors held 14,356 shares of UnitedHealth worth $3.88M as of Q1 2026.
  • Verdence Capital Advisors bought 4,185 UnitedHealth shares in Q1 2026, an estimated $1.25M.
  • UnitedHealth made up 0.23% of Verdence Capital Advisors's portfolio in Q1 2026, its #103 holding.
  • Verdence Capital Advisors first reported a position in UnitedHealth in Q4 2017 and has held it in 34 quarters since.
  • Verdence Capital Advisors's UnitedHealth position peaked at $9.91M in Q3 2024.
  • 3,021 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.